Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1973 1
1974 2
1976 2
1977 1
1978 2
1979 3
1980 2
1982 3
1983 2
1984 1
1985 4
1986 4
1987 3
1988 5
1989 10
1990 1
1991 6
1992 7
1993 5
1994 10
1995 4
1996 10
1997 8
1998 11
1999 6
2000 10
2001 11
2002 12
2003 12
2004 13
2005 25
2006 19
2007 19
2008 25
2009 18
2010 27
2011 33
2012 21
2013 25
2014 25
2015 27
2016 23
2017 32
2018 29
2019 27
2020 28
2021 37
2022 27
2023 21
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

609 results

Results by year

Filters applied: . Clear all
Page 1
Synovial Sarcoma: A Clinical Review.
Gazendam AM, Popovic S, Munir S, Parasu N, Wilson D, Ghert M. Gazendam AM, et al. Curr Oncol. 2021 May 19;28(3):1909-1920. doi: 10.3390/curroncol28030177. Curr Oncol. 2021. PMID: 34069748 Free PMC article. Review.
Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5-10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis and clinical presentation. ...
Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5-10% of all STS. Synovial s
Immunotherapy in Sarcoma: Where Do Things Stand?
Moreno Tellez C, Leyfman Y, D'Angelo SP, Wilky BA, Dufresne A. Moreno Tellez C, et al. Surg Oncol Clin N Am. 2022 Jul;31(3):381-397. doi: 10.1016/j.soc.2022.03.004. Surg Oncol Clin N Am. 2022. PMID: 35715140 Review.
Early experiences with modern immunotherapy have been disappointing in trials of unselected sarcoma subtypes. However, remarkable efficacy has been observed with immune checkpoint inhibitors (ICIs) in a subset of patients, with the most promising outcomes to date in alveol …
Early experiences with modern immunotherapy have been disappointing in trials of unselected sarcoma subtypes. However, remarkable eff …
Sarcomas of Soft Tissue and Bone.
Ferrari A, Dirksen U, Bielack S. Ferrari A, et al. Prog Tumor Res. 2016;43:128-41. doi: 10.1159/000447083. Epub 2016 Sep 5. Prog Tumor Res. 2016. PMID: 27595362 Review.
The definition of soft tissue and bone sarcomas include a large group of several heterogeneous subtypes of mesenchymal origin that may occur at any age. Among the different sarcomas, rhabdomyosarcoma, synovial sarcoma, Ewing sarcoma and osteosarcoma are aggre …
The definition of soft tissue and bone sarcomas include a large group of several heterogeneous subtypes of mesenchymal origin that may occur …
TP53 in bone and soft tissue sarcomas.
Thoenen E, Curl A, Iwakuma T. Thoenen E, et al. Pharmacol Ther. 2019 Oct;202:149-164. doi: 10.1016/j.pharmthera.2019.06.010. Epub 2019 Jul 2. Pharmacol Ther. 2019. PMID: 31276706 Free PMC article. Review.
Genomic and functional study of existing and emerging sarcoma targets, such as fusion proteins, chromosomal aberrations, reduced tumor suppressor activity, and oncogenic drivers, is broadening our understanding of sarcomagenesis. ...We have outlined nine bone and soft tiss …
Genomic and functional study of existing and emerging sarcoma targets, such as fusion proteins, chromosomal aberrations, reduced tumo …
Soft-tissue sarcoma in adolescents and young adults.
Kunisada T, Nakata E, Fujiwara T, Hosono A, Takihira S, Kondo H, Ozaki T. Kunisada T, et al. Int J Clin Oncol. 2023 Jan;28(1):1-11. doi: 10.1007/s10147-022-02119-7. Epub 2022 Jan 27. Int J Clin Oncol. 2023. PMID: 35084598 Review.
Soft-tissue sarcoma is a rare cancer that accounts for approximately 1% of all malignant tumors. ...This study aimed to evaluate the clinical and pathological characteristics of soft-tissue sarcoma in adolescents and young adults. According to the Bone and Soft-Tiss …
Soft-tissue sarcoma is a rare cancer that accounts for approximately 1% of all malignant tumors. ...This study aimed to evaluate the …
Periarticular calcifications.
Yan YY, Dous YNB, Ouellette HA, Munk PL, Murray N, Mallinson PI, Sheikh MA. Yan YY, et al. Skeletal Radiol. 2022 Mar;51(3):451-475. doi: 10.1007/s00256-021-03842-4. Epub 2021 Jun 21. Skeletal Radiol. 2022. PMID: 34155550 Review.
Metastasectomy in synovial sarcoma: A systematic review and meta-analysis.
Wang Y, Delisle M, Smith D, Alshamsan B, Srikanthan A. Wang Y, et al. Eur J Surg Oncol. 2022 Sep;48(9):1901-1910. doi: 10.1016/j.ejso.2022.05.022. Epub 2022 Jun 2. Eur J Surg Oncol. 2022. PMID: 35672231 Review.
BACKGROUND: Synovial sarcoma (SS) is a malignancy with high metastatic potential. ...
BACKGROUND: Synovial sarcoma (SS) is a malignancy with high metastatic potential. ...
A review on pulmonary and mediastinal synovial sarcoma.
Dewi KP, Dewi IP, Iswanto I, Wulandari L. Dewi KP, et al. J Basic Clin Physiol Pharmacol. 2023 Feb 20;34(2):169-175. doi: 10.1515/jbcpp-2022-0286. eCollection 2023 Mar 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 36800987 Review.
Synovial sarcoma is a rare soft tissue tumor originating from pluripotent with a high malignancy rate. The most common predilection of synovial sarcoma is in the joints. Primary synovial sarcoma of the lung and mediastinum are rare tumors
Synovial sarcoma is a rare soft tissue tumor originating from pluripotent with a high malignancy rate. The most common predile
KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.
Miettinen M, Lasota J. Miettinen M, et al. Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):205-20. doi: 10.1097/01.pai.0000173054.83414.22. Appl Immunohistochem Mol Morphol. 2005. PMID: 16082245 Review.
KIT positivity has been variably reported in sarcomas such as angiosarcoma, Ewing sarcoma, synovial sarcoma, leiomyosarcoma, and MFH; results of the last three are controversial. ...
KIT positivity has been variably reported in sarcomas such as angiosarcoma, Ewing sarcoma, synovial sarcoma, leiomyosar …
Sarcoma Stem Cell Heterogeneity.
Hatina J, Kripnerova M, Houfkova K, Pesta M, Kuncova J, Sana J, Slaby O, Rodríguez R. Hatina J, et al. Adv Exp Med Biol. 2019;1123:95-118. doi: 10.1007/978-3-030-11096-3_7. Adv Exp Med Biol. 2019. PMID: 31016597 Review.
These various origins result in substantial heterogeneity in possible sarcoma initiation. Genetic and epigenetic changes associated with sarcomagenesis profoundly impact the biology of sarcoma stem cells. For pediatric sarcomas featuring discrete reciprocal transloc …
These various origins result in substantial heterogeneity in possible sarcoma initiation. Genetic and epigenetic changes associated w …
609 results